Balyasny Asset Management’s Sabra Healthcare REIT SBRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $269K | Sell |
14,004
-1,902,251
| -99% | -$37.5M | ﹤0.01% | 2603 |
|
|
2025
Q4 | $36.3M | Buy |
1,916,255
+1,691,792
| +754% | +$31.4M | 0.05% | 459 |
|
|
2025
Q3 | $4.18M | Sell |
224,463
-2,484,574
| -92% | -$46.4M | 0.01% | 1444 |
|
|
2025
Q2 | $50M | Buy |
+2,709,037
| New | +$48.1M | 0.08% | 330 |
|
|
2023
Q2 | – | Sell |
-1,119,940
| Closed | -$12.9M | – | 2735 |
|
|
2023
Q1 | $12.9M | Buy |
+1,119,940
| New | +$13.9M | 0.03% | 678 |
|
|
2022
Q4 | – | Sell |
-2,136,468
| Closed | -$28M | – | 3183 |
|
|
2022
Q3 | $28M | Buy |
2,136,468
+2,102,666
| +6,221% | +$31.1M | 0.09% | 310 |
|
|
2022
Q2 | $472K | Buy |
+33,802
| New | +$452K | ﹤0.01% | 1993 |
|
|
2022
Q1 | – | Sell |
-1,409,487
| Closed | -$19.1M | – | 2801 |
|
|
2021
Q4 | $19.1M | Buy |
+1,409,487
| New | +$19.9M | 0.07% | 431 |
|
|
2021
Q3 | – | Sell |
-354,750
| Closed | -$6.46M | – | 2368 |
|
|
2021
Q2 | $6.46M | Sell |
354,750
-532,998
| -60% | -$9.49M | 0.03% | 634 |
|
|
2021
Q1 | $15.4M | Buy |
887,748
+251,936
| +40% | +$4.43M | 0.08% | 358 |
|
|
2020
Q4 | $11M | Buy |
635,812
+505,541
| +388% | +$8.07M | 0.06% | 411 |
|
|
2020
Q3 | $1.8M | Buy |
+130,271
| New | +$1.91M | 0.01% | 863 |
|
|
2020
Q2 | – | Sell |
-691,929
| Closed | -$7.56M | – | 1448 |
|
|
2020
Q1 | $7.56M | Sell |
691,929
-29,255
| -4% | -$539K | 0.09% | 304 |
|
|
2019
Q4 | $15.4M | Buy |
+721,184
| New | +$16.1M | 0.09% | 321 |
|
|
2019
Q3 | – | Sell |
-574,581
| Closed | -$11.3M | – | 1526 |
|
|
2019
Q2 | $11.3M | Buy |
574,581
+15,126
| +3% | +$295K | 0.07% | 370 |
|
|
2019
Q1 | $10.9M | Buy |
559,455
+338,990
| +154% | +$6.42M | 0.07% | 363 |
|
|
2018
Q4 | $3.63M | Buy |
220,465
+203,961
| +1,236% | +$4.11M | 0.03% | 570 |
|
|
2018
Q3 | $382K | Sell |
16,504
-13,630
| -45% | -$309K | ﹤0.01% | 1448 |
|
|
2018
Q2 | $655K | Sell |
30,134
-1,716,863
| -98% | -$33.5M | ﹤0.01% | 1258 |
|
|
2018
Q1 | $30.8M | Buy |
1,746,997
+909,164
| +109% | +$16M | 0.13% | 221 |
|
|
2017
Q4 | $15.7M | Buy |
837,833
+356,937
| +74% | +$7.1M | 0.05% | 492 |
|
|
2017
Q3 | $10.6M | Buy |
+480,896
| New | +$10.9M | 0.04% | 485 |
|
|
2016
Q2 | – | Sell |
-35,664
| Closed | -$716K | – | 1408 |
|
|
2016
Q1 | $716K | Sell |
35,664
-842,019
| -96% | -$16.1M | ﹤0.01% | 816 |
|
|
2015
Q4 | $17.8M | Buy |
+877,683
| New | +$18.5M | 0.12% | 230 |
|
|
2014
Q4 | – | Sell |
-732,000
| Closed | -$17.8M | – | 814 |
|
|
2014
Q3 | $17.8M | Buy |
732,000
+415,000
| +131% | +$11.5M | 0.14% | 192 |
|
|
2014
Q2 | $9.1M | Buy |
+317,000
| New | +$9.21M | 0.1% | 254 |
|
|
2013
Q4 | – | Sell |
-143,700
| Closed | -$3.31M | – | 613 |
|
|
2013
Q3 | $3.31M | Sell |
143,700
-89,968
| -39% | -$2.22M | 0.04% | 410 |
|
|
2013
Q2 | $6.1M | Buy |
+233,668
| New | +$6.74M | 0.1% | 243 |
|
Other funds holding SBRA
VPM
VCM
N
Balyasny Asset Management's SBRA Position: Q1 2026 in Review
Balyasny Asset Management reduced its Sabra Healthcare REIT (SBRA) stake by 99% in Q1 2026, selling an estimated $37.5M and leaving 14,004 shares worth $269K. The position accounts for ﹤0.01% of the portfolio, ranked #2603.
Balyasny Asset Management first reported a position in SBRA in Q2 2013 and has held it in 28 quarters since. The position peaked at $50M in Q2 2025. 459 funds tracked by Wall St. Rank hold SBRA as of Q1 2026.
- Balyasny Asset Management held 14,004 shares of Sabra Healthcare REIT worth $269K as of Q1 2026.
- Balyasny Asset Management sold 1,902,251 Sabra Healthcare REIT shares in Q1 2026, an estimated $37.5M.
- Sabra Healthcare REIT made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #2603 holding.
- Balyasny Asset Management first reported a position in Sabra Healthcare REIT in Q2 2013 and has held it in 28 quarters since.
- Balyasny Asset Management's Sabra Healthcare REIT position peaked at $50M in Q2 2025.
- 459 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2026.
Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.